We got permission to continue following the patients in this study and we also recruited
a second cohort of patients to try to run a series of placebo controlled studies.
Not exact matches
In the
second cohort of 77 COPD
patients, the 23
patients with allergic sensitization (determined by immunoglobulin E testing) were significantly more likely to wheeze, to experience nighttime awakening due to cough, and to have COPD exacerbations requiring antibiotic treatment or an acute visit to the doctor.
The
second cohort of 140
patients with human leukocyte antigen - matched unrelated donor transplants completed enrollment in November 2017, with data expected from this randomized double - blind arm
of the study in the next six months.
A
second cohort of up to 40
patients is expected to begin enrolling later this year to evaluate both safety and efficacy.